- Home
- SNCR vs PMVP Comparison
SNCR vs PMVP Comparison
Compare SNCR & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNCR
- PMVP
- Stock Information
- Founded
- SNCR 2000
- PMVP 2013
- Country
- SNCR United States
- PMVP United States
- Employees
- SNCR N/A
- PMVP N/A
- Industry
- SNCR EDP Services
- PMVP Medicinal Chemicals and Botanical Products
- Sector
- SNCR Technology
- PMVP Health Care
- Exchange
- SNCR Nasdaq
- PMVP Nasdaq
- Market Cap
- SNCR 87.5M
- PMVP 62.3M
- IPO Year
- SNCR 2006
- PMVP 2020
- Fundamental
- Price
- SNCR $7.26
- PMVP $1.34
- Analyst Decision
- SNCR Strong Buy
- PMVP Strong Buy
- Analyst Count
- SNCR 1
- PMVP 1
- Target Price
- SNCR $13.00
- PMVP $5.00
- AVG Volume (30 Days)
- SNCR 144.3K
- PMVP 239.6K
- Earning Date
- SNCR 08-05-2025
- PMVP 08-07-2025
- Dividend Yield
- SNCR N/A
- PMVP N/A
- EPS Growth
- SNCR N/A
- PMVP N/A
- EPS
- SNCR N/A
- PMVP N/A
- Revenue
- SNCR $172,842,000.00
- PMVP N/A
- Revenue This Year
- SNCR $2.07
- PMVP N/A
- Revenue Next Year
- SNCR $5.42
- PMVP N/A
- P/E Ratio
- SNCR N/A
- PMVP N/A
- Revenue Growth
- SNCR 4.64
- PMVP N/A
- 52 Week Low
- SNCR $6.00
- PMVP $0.81
- 52 Week High
- SNCR $15.46
- PMVP $1.82
- Technical
- Relative Strength Index (RSI)
- SNCR 53.01
- PMVP 72.39
- Support Level
- SNCR $7.42
- PMVP $0.96
- Resistance Level
- SNCR $7.98
- PMVP $1.36
- Average True Range (ATR)
- SNCR 0.43
- PMVP 0.09
- MACD
- SNCR 0.11
- PMVP 0.02
- Stochastic Oscillator
- SNCR 71.54
- PMVP 95.31
About SNCR Synchronoss Technologies Inc.
Synchronoss Technologies Inc is a provider of white-label cloud, messaging, digital and network management solutions that enable its customers to keep subscribers, systems, networks and content in sync. The Synchronoss Personal CloudTM solution is designed to create an engaging and trusted customer experience through ongoing content management and engagement. The Synchronoss Personal CloudTM platform is a secure and scalable, white-label platform that allows its customers' subscribers to backup and protect, engage with, and manage their personal content. The company derives revenue from subscriptions and transaction-based fees. A majority of the firm's revenue is generated in the United States, and the rest is from countries across the world.
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.